Results 251 to 260 of about 4,880,179 (312)

Pharmacovigilance: the evolution of drug safety monitoring. [PDF]

J Pharm Policy Pract
Khan MAA, Sara T, Babar ZU.
europepmc   +1 more source

How is Nanoarchitectonics Shaping Extracellular Vesicle Research?

Advanced Healthcare Materials, EarlyView.
The convergence of nanoarchitectonics and extracellular vesicle biology is reshaping next‐generation nanomedicine by enabling rationally designed nanostructures for enhanced EVs detection, engineering, and therapy. ABSTRACT Extracellular vesicles (EVs) have gained recognition as crucial mediators of cell‐to‐cell communication, holding immense potential
Madushani Dahanayake, Md Shahriar A. Hossain, Chia‐Hung Liu, Carlos Salomon, Yusuke Yamauchi, Mostafa Kamal Masud   +5 more
wiley   +1 more source

Research and practice on key drug safety monitoring under the normalization of centralized procurement: A case study of 13 selected drugs in a Province. [PDF]

Medicine (Baltimore)
Ding G, Ding J.
europepmc   +1 more source

Making the Case for Organ‐on‐Chip Platforms in Long‐Acting Therapeutics Development

Advanced Healthcare Materials, EarlyView.
LATs release drug from a tissue‐resident depot over weeks to months, improving adherence, but their development is hampered by preclinical models that cannot reproduce the coupled tissue processes, sustained release, local microenvironment change, interstitial transport, immune and foreign‐body responses, and clearance that govern depot performance in ...
Charlie Gowans, Abdulwahhab Khedr, Panagiotis G. Georgiou, Nehir Arik, Ozlem Sen, Steve P. Rannard, Tom O. McDonald, Christos Tapeinos   +7 more
wiley   +1 more source

Assessing the real-world drug safety of sevelamer for hyperphosphatemia: Insights from a comprehensive analysis of the FDA adverse event reporting system (FAERS) database. [PDF]

Medicine (Baltimore)
Shao X, Yang H, Tan C, Liu J, Zhou L.
europepmc   +1 more source

Performance of the Self-Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the French Administrative Healthcare Database (SNDS). [PDF]

Pharmacoepidemiol Drug Saf
Coste A, Wong AYS, Haguinet F, Bate A, Douglas IJ.   +4 more
europepmc   +1 more source

Rethinking drug safety signal detection and causality assessment in the age of AI: the risks of incomplete data and biased insights. [PDF]

Front Drug Saf Regul
Chhikara P, Hammad TA.
europepmc   +1 more source

Outpatient interface challenges for drug safety in Parkinson's disease patients: a questionnaire based cross-sectional study. [PDF]

Front Neurol
Greten S, Niesmann C, Krey L, Heck J, Wegner F, Klietz M.   +5 more
europepmc   +1 more source

Navigating Diverging Perspectives: Reasoning, Evidence, and Decision-Making in Drug Safety. [PDF]

Drug Saf
Hammad TA, Davies S.
europepmc   +1 more source

REMS Logic Model: A Pragmatic Framework for Incorporating Drug Safety into Clinical Practice. [PDF]

Drug Saf
Toyserkani GA, Robottom SB, Morrato EH.
europepmc   +1 more source